摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methyl-1-(3,4-ethylenedioxyphenyl)-2-aminopropane | 133787-66-3

中文名称
——
中文别名
——
英文名称
N-methyl-1-(3,4-ethylenedioxyphenyl)-2-aminopropane
英文别名
3,4-ethylenedioxymethamphetamine;(±)-1-(3,4-ethylenedioxyphenyl)-N-methyl-2-aminopropane;EDMA;Ethylenedioxymethylamphetamine;1-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-methylpropan-2-amine
N-methyl-1-(3,4-ethylenedioxyphenyl)-2-aminopropane化学式
CAS
133787-66-3
化学式
C12H17NO2
mdl
——
分子量
207.272
InChiKey
UJKWLAZYSLJTKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-methyl-1-(3,4-ethylenedioxyphenyl)-2-aminopropane盐酸 作用下, 以 乙醚乙醇 为溶剂, 以0.03 g的产率得到(±)-1-(3,4-ethylenedioxyphenyl)-N-methyl-2-aminopropane hydrochloride
    参考文献:
    名称:
    Ethylenedioxy homologs of N -methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine
    摘要:
    N-Methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA; 'Ecstasy'; 1) and its beta-keto analog methylone (MDMC; 2) are popular drugs of abuse. Little is known about their ring-expanded ethylenedioxy homologs. Here, we prepared N-methyl-(3,4-ethylenedioxyphenyl)-2-aminopropane (EDMA; 3), both of its optical isomers, and beta-keto EDMA (i.e., EDMC; 4) to examine their effects at transporters for serotonin (SERT), dopamine (DAT), and norepinephrine (NET). In general, ring-expansion of the methylenedioxy group led to a several-fold reduction in potency at all three transporters. With respect to EDMA (3), S(+)3 was 6-fold, 50-fold, and 8-fold more potent than its R(-) enantiomer at SERT, DAT, and NET, respectively. Overall, in the absence of a beta-carbonyl group, the ethylenedioxy (i.e., 1,4-dioxane) substituent seems better accommodated at SERT than at DAT and NET. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2015.07.035
  • 作为产物:
    描述:
    在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 N-methyl-1-(3,4-ethylenedioxyphenyl)-2-aminopropane
    参考文献:
    名称:
    Ethylenedioxy homologs of N -methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine
    摘要:
    N-Methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA; 'Ecstasy'; 1) and its beta-keto analog methylone (MDMC; 2) are popular drugs of abuse. Little is known about their ring-expanded ethylenedioxy homologs. Here, we prepared N-methyl-(3,4-ethylenedioxyphenyl)-2-aminopropane (EDMA; 3), both of its optical isomers, and beta-keto EDMA (i.e., EDMC; 4) to examine their effects at transporters for serotonin (SERT), dopamine (DAT), and norepinephrine (NET). In general, ring-expansion of the methylenedioxy group led to a several-fold reduction in potency at all three transporters. With respect to EDMA (3), S(+)3 was 6-fold, 50-fold, and 8-fold more potent than its R(-) enantiomer at SERT, DAT, and NET, respectively. Overall, in the absence of a beta-carbonyl group, the ethylenedioxy (i.e., 1,4-dioxane) substituent seems better accommodated at SERT than at DAT and NET. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2015.07.035
点击查看最新优质反应信息

文献信息

  • [EN] ACYCLIC CUCURBIT(N)URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS<br/>[FR] RECIPIENTS MOLECULAIRES DE TYPE CUCURBIT(N)URIL ACYCLIQUE POUR TRAITER L'INTOXICATION ET REDUIRE LE TAUX DE RECHUTE DANS DES TROUBLES DE TOXICOMANIE
    申请人:UNIV MARYLAND
    公开号:WO2016061571A1
    公开(公告)日:2016-04-21
    Provided are methods for reversing the effects of drugs of abuse. The method involves administering acyclic CB[n]-type compounds to a mammal in need of the reversal of the effects from a drug of abuse.
    提供了逆转药物滥用效果的方法。该方法涉及向需要逆转药物滥用效果的哺乳动物施用非环CB[n]型化合物。
  • Method for fabrication of biochips with a macroporous polymer substrate
    申请人:Kukhtin V. Alexander
    公开号:US20050042363A1
    公开(公告)日:2005-02-24
    Macroporous polymer substrates have greater immobilization capacity for large biomolecules and better access for analytes than substrates used previously for microarrays. Microarrays are fabricated with macroporous polymer substrates, and nucleic acids, proteins and peptides are immobilized in the substrate. Microarrays with macroporous polymer substrates are useful in immunoassays, drug discovery studies and other biotechnological applications that involve large scale macromolecular interactions. Nucleic acid hybridizations, protein binding, and antigen-antibody interactions are analyzed using microarrays with macroporous polymer substrates.
    具有大分子固定能力和更好的物质分析接近度的多孔聚合物基底,比以前用于微阵列的基底更为优越。采用多孔聚合物基底制造微阵列,核酸、蛋白质和肽类被固定在基底中。具有多孔聚合物基底的微阵列在免疫测定、药物发现研究以及涉及大规模高分子相互作用的其他生物技术应用中非常有用。利用具有多孔聚合物基底的微阵列分析核酸杂交、蛋白质结合和抗原-抗体相互作用。
  • ASSAY DEVICES AND METHODS AND COMPONENTS FOR USE THEREIN
    申请人:Self Colin Henry
    公开号:US20100209295A1
    公开(公告)日:2010-08-19
    Dipsticks and other assay devices suitable for the assay of haptens are disclosed. Also disclosed are blocking agents for use in such devices.
    本发明公开了适用于测定半抗原的液滴试纸和其他测定装置。还公开了用于这种装置的阻断剂。
  • Surfactant-Based Monolithic Columns, Methods for Making the Same, and Method for Using the Same
    申请人:Shamsi Shahab Ahmed
    公开号:US20110086409A1
    公开(公告)日:2011-04-14
    A method for making a surfactant-based monolithic column is provided. The method comprises providing a mixture comprising at least one surfactant monomer, at least one crosslinker, at least one initiator, and at least one porogen and polymerizing the mixture to form the surfactant-based monolithic column. The present disclosure also provides a surfactant-based monolithic column, a method for separating molecules, and a process for preparing a surfactant monomer.
    提供了一种制备基于表面活性剂的单体柱的方法。该方法包括提供一种混合物,其中包括至少一种表面活性剂单体、至少一种交联剂、至少一种引发剂和至少一种孔原。将该混合物聚合成表面活性剂基的单体柱。本公开还提供了一种基于表面活性剂的单体柱、分离分子的方法和制备表面活性剂单体的过程。
  • COMPOSITION FOR FORMING A DEVELOPABLE BOTTOM ANTIREFLECTIVE COATING
    申请人:NAKASUGI Shigemasa
    公开号:US20140193753A1
    公开(公告)日:2014-07-10
    The present invention provides a composition for forming a bottom anti-reflective coating, and also provides a photoresist pattern formation method employing that composition. The composition gives a bottom anti-reflective coating used in a lithographic process for manufacturing semiconductor devices, and the coating can be developed with a developing solution for photoresist. The composition contains a solvent, a polymer having a condensed polycyclic aromatic group, and a compound having a maleimide derivative or a maleic anhydride derivative. The composition may further contain a photo acid generator or a crosslinking agent.
    本发明提供一种用于形成底部抗反射涂层的组合物,并提供一种采用该组合物的光阻图案形成方法。该组合物可用于制造半导体器件的光刻过程中的底部抗反射涂层,并且可用光阻显影液进行显影。该组合物包含溶剂、具有紧缩多环芳香基团的聚合物以及具有马来酰亚胺衍生物或马来酸酐衍生物的化合物。该组合物还可以进一步包含光酸发生剂或交联剂。
查看更多

同类化合物

顺式-6-氯-4-甲基-4-苯基-4H-1,3-苯并二氧杂环己-2-羧酸 阿莫齐特 苯并二氧六环-6-甲酸甲酯 苯并二氧六环-6-甲酰胺 苯并二氧六环-5-甲酸甲酯 苯并二氧六环-5-甲酰胺 苯并二氧六环-2-磺酰氯 苯并-1,4-二氧六环-6-硼酸 艾泽罗西 胍苯克生 胍美柳 胍生 羧基-6-苯并(4H)二恶英-1,3 美商陆酚A 维兰特罗杂质4 盐酸艾美洛沙 盐酸哌罗克生 盐酸[(7-溴-2,3-二氢-1,4-苯并二恶英-6-基)甲基]肼 甲基氨基甲酸1,4-苯并二恶烷-5-基酯 甲基8-甲基-2,3-二氢-1,4-苯并二氧杂环己烷-6-羧酸酯 甲基7-甲基-2,3-二氢-1,4-苯并二氧杂环己烷-5-羧酸酯 甲基4-[(1E)-3-乙基-3-(羟甲基)三氮杂-1-烯-1-基]苯酸酯 甲基-[2-[(7-丙-2-烯基-2,3-二氢-1,4-苯并二氧杂环己-8-基)氧基]乙基]氯化铵 甲基(2S,4R)-6-氯-4-甲基-4-(2-噻吩基)-4H-1,3-苯并二氧杂环己烷-2-羧酸酯 溴(2,3-二氢-1,4-苯并二氧杂环己-6-基)镁 沙丁胺醇缩丙酮 异戊苯恶烷 度莫辛 布他莫生 安必罗山 地奥地洛 哌扑罗生 咪洛克生 咪唑克生盐酸盐 吡啶-3-磺酰氯盐酸盐 叔丁基 (2,3-二氢苯并[b][1,4]二噁英-6-基)氨基甲酸酯 反式-2,3-二氢-N-((4-(2-苯氧基乙基)-1-哌嗪基)甲基)-1,4-苯并二氧六环-2-甲酰胺 双恶哌嗪 冰达卡醇 依利格鲁司特中间体5 依利格鲁司特 亚达唑散 二氨基亚甲基-(2,3-二氢-1,4-苯并二氧杂环己-2-基甲基)铵硫酸盐 二-(叔丁基)2-(2,2-二甲基-4H-1,3-苯并二恶英-6-基)-2-氧代乙基亚氨基二碳酸 二(吡咯烷甲基)-4-羟基苯基乙酸1,4-苯并二噁烷基-2-甲基酯 乙基2,3-二氢-1,4-苯并二氧杂环己-6-基(氧代)乙酸酯 三氟甲烷磺酸7-甲氧基-2,2-二甲基-4-氧代-4H-1,3-苯并二氧杂环己-5-基酯 alpha-[[N-(2-甲氧基乙基)甲基氨基]甲基]-1,4-苯并二恶烷-2-甲醇 alpha-[[(4-甲氧基丁基)甲基氨基]甲基]-1,4-苯并二恶烷-2-甲醇 alpha-[[(4-甲氧基丁基)氨基]甲基]-alpha-甲基-1,4-苯并二恶烷-2-甲醇